Dr. Mamounas On Adjuvant Endocrine Therapy For Breast Cancer

Dr. Mamounas on Adjuvant Endocrine Therapy for Breast Cancer

Dr. Mamounas on the Role of Extended Adjuvant Endocrine Therapy in ER+ Breast Cancer

Dr. Mamounas on Patient Selection for Endocrine Therapy

Breast Cancer: Extended Adjuvant Endocrine Therapy

Adjuvant endocrine therapy for breast cancer: optimal durations and regimens

Exploring Adjuvant Endocrine Therapy in the Breast Cancer Setting

Targeted Oncology

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

Dr. Mamounas on Neoadjuvant Chemotherapy for Breast Cancer

Dr. Burstein on Adjuvant Endocrine Therapy for ER+ Breast Cancer

Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer

Exploring Extended Adjuvant Endocrine Therapy for HR+ Breast Cancer

Targeted Oncology

Dr. Terry Mamounas Eleftherios | Clinical Controversies | San Antonio Breast Cancer Symposium 2022

San Antonio Breast Cancer Symposium

Exploring adjuvant endocrine therapy use with letrozole in postmenopausal women with hormone rec...

Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer

Challenges With Neoadjuvant Endocrine Therapy in Breast Cancer

Targeted Oncology

monarchE: abemaciclib and adjuvant endocrine therapy for high-risk HR+ early breast cancer

Dr. Mamounas on Selecting Patients With Breast Cancer for Neoadjuvant Chemotherapy

Dr. Rugo on Extended Adjuvant Hormone Therapy for Breast Cancer

Updates in Extended Endocrine Therapy for HR+ Breast Cancer | ASCO21 & National Practice Guidelines

Total Health | Oncology

Dr. Mamounas on Future of Surgical Treatments in Breast Cancer